Page 2 - Minvest Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Minvest partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Minvest Partners Today - Breaking & Trending Today

Advisory Services Network LLC Purchases 2,362 Shares of Boston Scientific Co. (NYSE:BSX)

Advisory Services Network LLC grew its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 5.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,398 shares of the medical equipment provider’s stock after purchasing an additional 2,362 […] ....

Sakhalinskaya Oblast , United States , Eric Francis Yves Thepaut , Charlesj Dockendorff , Securities Exchange Commission , Advisory Services Network , Boston Scientific Corporation , Glenmede Trust Co , Boston Scientific , Mackenzie Financial Corp , Exchange Commission , Wells Fargo Company , Boston Scientific Co , Victory Capital Management Inc , Free Report , Services Network , Capital Management , State Employees Retirement System , Minvest Partners , Financial Corp , Get Free Report , Francis Yves Thepaut , Director Charles , Scientific Corporation , Visit Holdingschannel , Boston Scientific Daily ,

JARISLOWSKY FRASER Ltd Has $175.06 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX)

JARISLOWSKY FRASER Ltd trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,028,215 shares of the medical equipment provider’s stock after selling 56,630 shares during the period. […] ....

United States , Wendy Carruthers , Edwardj Ludwig , Boston Scientific Corporation , Securities Exchange Commission , Mackenzie Financial Corp , Wells Fargo Company , Victory Capital Management Inc , Deutsche Bank Aktiengesellschaft , Boston Scientific Co , Glenmede Trust Co , Boston Scientific , Free Report , Capital Management , State Employees Retirement System , Minvest Partners , Financial Corp , Director Edward , Exchange Commission , Get Free Report , Bank Aktiengesellschaft , Scientific Corporation , Visit Holdingschannel , Boston Scientific Daily ,

Merus (NASDAQ:MRUS) Reaches New 52-Week High Following Analyst Upgrade

Merus (NASDAQ:MRUS – Get Free Report)’s stock price hit a new 52-week high during trading on Friday after Bank of America raised their price target on the stock from $52.00 to $61.00. Bank of America currently has a buy rating on the stock. Merus traded as high as $57.80 and last traded at $58.00, with […] ....

United States , Stifel Nicolaus , Needham Company , Swiss National Bank , Get Free Report , Minvest Partners , Capital Partners , Bay Capital Management , National Bank , Merus Daily ,

Cytokinetics (NASDAQ:CYTK) Price Target Cut to $70.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective decreased by Raymond James from $92.00 to $70.00 in a research note released on Thursday, Benzinga reports. Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. Truist Financial reissued a buy rating and […] ....

Fady Ibraham Malik , Raymond James , Johnt Henderson , Victory Capital Management Inc , Vanguard Group Inc , Cytokinetics Company Profile , Needham Company , Legato Capital Management , Cytokinetics Incorporated , Free Report , Moderate Buy , Get Free Report , Ibraham Malik , Director John , Minvest Partners , Capital Management , Victory Capital Management , Cytokinetics Daily ,

Cytokinetics (NASDAQ:CYTK) Given New $72.00 Price Target at Needham & Company LLC

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Needham & Company LLC from $108.00 to $72.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CYTK. Mizuho reduced […] ....

Fady Ibraham Malik , Johnt Henderson , Cytokinetics Incorporated , Legato Capital Management , Needham Company , Vanguard Group Inc , Victory Capital Management Inc , Securities Exchange Commission , Free Report , Moderate Buy , Get Free Report , Director John , Exchange Commission , Ibraham Malik , Minvest Partners , Capital Management , Victory Capital Management , Cytokinetics Daily ,